FDA warns of allergy risk with Merck antipsychotic
Key points
- The Food and Drug Administration warned on Thursday that serious allergic reactions have been reported with the use of Merck & Co Inc's antipsychotic drug Saphris.
- The agency said the drug's label has been revised to include information about the risk.
- Saphris, first approved in 2009, is used to treat symptoms of schizophrenia and bipolar disorder.
- Doctors should closely monitor patients for reactions including anaphylaxis, swelling, low blood pressure and swollen tongue, the FDA said in a notice on its website.
The Food and Drug Administration warned on Thursday that serious allergic reactions have been reported with the use of Merck & Co Inc's antipsychotic drug Saphris.
The agency said the drug's label has been revised to include information about the risk.
Saphris, first approved in 2009, is used to treat symptoms of schizophrenia and bipolar disorder.
Doctors should closely monitor patients for reactions including anaphylaxis, swelling, low blood pressure and swollen tongue, the FDA said in a notice on its website.
The agency said Saphris should not be used in patients with a known hypersensitivity to the drug and patients should seek emergency medical attention if they develop any signs and symptoms of a serious allergic reaction while taking Saphris.
###
(Reuters)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →NewsRisk of motor vehicle accidents is higher in people with sleep apnea
A new study finds that obstructive sleep apnea is associated with a significantly increased risk of motor vehicle accidents, and this risk is reduced when sleep apnea is treated effectively using continuous positive…
11 March 2015
NewsExposure to mercury, seafood associated with risk factor for autoimmune disease
One of the greatest risk factors for autoimmunity among women of childbearing age may be associated with exposure to mercury such as through seafood, a new University of Michigan study says. The findings, which appear…
11 February 2015
NewsPhthalates heighten risk for childhood asthma
Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates…